Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer in Russian Federation (Market Wired)

 

(Buffalo, NY) Cleveland BioLabs Inc. receive approval from the Russian Ministry of health to begin phase 1 clinical trials for the induction and mobilization of hematopoietic stem cells.